Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: Implication in psychiatric disorders of developmental origin

Neuroscience Research

Volumn 50, Issue 1, 2004, Pages 67-75

  Tohmi, Manavu ^a   Tsuda, Noriko ^a   Watanabe, Yuichiro ^a   Kakita, Akiyoshi ^a   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

ADHD; Autism; IFN; IL; IL 1; IL 2; IL 6; Inflammation; interferon; Interferon; interleukin; PND; postnatal day; PPI; prepulse inhibition; Schizophrenia

Indexed keywords

CLOZAPINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFECT; EYELID MOVEMENT; FEAR; JUVENILE; LATENT PERIOD; LOCOMOTION; MOTOR ACTIVITY; NEWBORN; NONHUMAN; PHYSICAL DEVELOPMENT; POSTNATAL DEVELOPMENT; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SOCIAL INTERACTION; STARTLE REFLEX; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; INTERFERON TYPE II; INTERLEUKINS; MENTAL DISORDERS; MOTOR ACTIVITY; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION;

EID: 3543121321     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.05.010     Document Type: Article

References (57)

1. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., Gennarelli M. Association between G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol. Psychiatry. 6:2001;79-82
2. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology. 26:2002;204-215
3. Cai Z., Pan Z.L., Pang Y., Evans O.B., Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47:2000;64-72
4. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry. 159:2002;1080-1092
5. Chrapusta S.J., Egan M.F., Wyatt R.J., Weinberger D.R., Lipska B.K. Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse. 47:2003;270-277
6. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84:1998;923-933
7. Conti L.H., Murry J.D., Ruiz M.A., Printz M.P. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology (Berl.). 161:2002;296-303
8. Dirks A., Groenink L., Westphal K.G., Olivier J.D., Verdouw P.M., van der Gugten J., Geyer M.A., Olivier B. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by anti-psychotic drugs. Neuropsychopharmacology. 28:2003;1790-1798
9. Engel J.A., Zhang J., Bergstrom T., Conradi N., Forkstam C., Liljeroth A., Svensson L. Neonatal herpes simplex virus type 1 brain infection affects the development of sensorimotor gating in rats. Brain Res. 863:2000;233-240
10. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., Shi L., Sidwell R. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol. Neurobiol. 22:2002;25-33
11. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238
12. Futamura T., Kakita A., Tohmi M., Sotoyama H., Takahashi H., Nawa H. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol. Psychiatry. 8:2003;19-29
13. Gilmore J.H., Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr. Res. 24:1997;365-367
14. Halgunset J., Johnsen H., Kjollesdal A.M., Qvigstad E., Espevik T., Austgulen R. Cytokine levels in amniotic fluid and inflammatory changes in the placenta from normal deliveries at term. Eur. J. Obstet. Gynecol. Reprod. Biol. 56:1994;153-160
15. Hamon M., Doucet E., Lefevre K., Miquel M.-C., Lanfumey L., Insausti R., Frechilla D., Del Rio J., Verge D. Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsycopharmacology. 21:1999;68-76
16. Ho A., Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci. 18:1998;5614-5629
17. Irvine E.E., Cheeta S., Marchall M., File S.E. Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects. Pharmacol. Biochem. Behav. 68:2001;769-776
18. Katila H., Appelberg B., Hurme M., Rimon R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr. Res. 12:1994;29-34
19. Katila H., Hanninen K., Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol. Psychiatry. 4:1999;179-181
20. Kimura M., Toth L.A., Agostini H., Cady A.B., Majde J.A., Krueger J.M. Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am. J. Physiol. 267:1994;R1596-1605
21. Kirch D.G. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19:1993;355-370
22. Kobayashi M., Imamura K., Sugai T., Onoda N., Yamamoto M., Komai S., Watanabe Y. Selective suppression of horizontal propagation in rat visual cortex by norepinephrine. Eur. J. Neurosci. 12:2000;264-272
23. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Trends Neurosci. 25:2002;154-159
24. Kontkanen O., Toronen P., Lakso M., Wong G., Castren E. Anti-psychotic drug treatment induces differential gene expression in the rat cortex. J. Neurochem. 83:2002;1043-1053
25. Kunugi H., Nanko S., Takei N. Influenza and schizophrenia in Japan. Br. J. Psychiatry. 161:1992;274-275
26. Licinio J., Seibyl J.P., Altemus M., Charney D.S., Krystal J.H. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am. J. Psychiatry. 150:1993;1408-1410
27. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., Pioli R., Altamura C., Scharpe S., Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32:1998;9-15
28. Ling Z.D., Potter E.D., Lipton J.W., Carvey P.M. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol. 149:1998;411-423
29. Lipska B.K., Aultman J.M., Verma A., Weinberger D.R., Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology. 27:2002;47-54
30. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.L., Swedo S.E., Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J. Immunol. 159:1997;2994-2999
31. Muller N., Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatricdisorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22:1998;1-33
32. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder? Br. Med. J. 295:1987;681-682
33. Nawa H., Takahasi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia - support for the development model. Mol. Psychiatry. 5:2000;594-603
34. O'Callaghan E., Sham P., Takei N., Glover G., Murray R.M. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet. 337:1991;1248-1250
35. O'Callaghan E., Gibson T., Colohan H.A., Buckley P., Walshe D.G., Larkin C., Waddington J.L. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. Br. Med. J. 305:1992;1256-1259
36. Olivier B., Mos J., van der Heyden J., Hartog J. Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology (Berl.). 97:1989;154-156
37. Romero R., Avila C., Santhanam U., Sehgal P.B. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J. Clin. Invest. 85:1990;1392-1400
38. Rothschild D.M., O'Grady M., Wecker L. Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: implications for schizophrenia. J. Neurosci. Res. 57:1999;429-434
39. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23:2000;618-625
40. Sams-Dodd F. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev. Neurosci. 10:1999;59-90
41. Sarandakou A., Giannaki G., Malamitsi-Puchner A., Rizos D., Hourdaki E., Protonotariou E., Phocas I. Inflammatory cytokines in newborn infants. Mediators Inflamm. 7:1998;309-312
42. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23:2003;297-302
43. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci. 13:1993;3574-3581
44. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Aiso S., Kato R., Asai M. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J. Neurosci. 15:1995;1961-1970
45. Song C., Merali Z., Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 88:1999;823-836
46. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24:1998;285-301
47. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P., Braff D.L., Geyer M.A. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J. Neurosci. 20:2000;4325-4336
48. Torrey E.F., Rawlings R., Waldman I.N. Schizophrenic births and viral diseases in two states. Schizophr. Res. 1:1988;73-77
49. Toyooka K., Watanabe Y., Iritani S., Shimizu E., Iyo M., Nakamura R., Asama K., Makifuchi T., Kakita A., Takahashi H., Someya T., Nawa H. A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients. Neurosci. Res. 46:2003;299-307
50. van Os J., Selten J.P. Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br. J. Psychiatry. 172:1998;324-326
51. Vereker E., O'Donnell E., Lynch M.A. The inhibitory effect of interleukin-1β on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20:2000;6811-6819
52. Watanabe M., Lee B.J., Yamashita M., Kamitani W., Kobayashi T., Tomonaga K., Ikuta K. Borna disease virus induces acute fatal neurological disorders in neonatal gerbils without virus- and immune-mediated cell destructions. Virology. 310:2003;245-253
53. Watanabe Y., Hashimoto S., Kakita A., Takahashim H., Ko K., Mizuno M., Someya T., Patterson P., Nawa H. Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats. Neurosci. Res. 48:2004;345-353
54. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669
55. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Seishima M., Nabeshima T. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J. Neuroimmunol. 111:2000;131-138
56. Zalcman S., Murray L., Dyck D.G., Greenberg A.H., Nance D.M. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res. 811:1998;111-121
57. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology. 28:2003;1778-1789